Adviser CRD 137611 is not on the SEC registered or exempt adviser roster of 2026-09-01
LTS Capital Partners--Fallbrook VII, LLC first reported on Form ADV by LTS Capital Advisors (Private Equity Fund), GAV $1,500,000
LTS Capital Partners--Bio2 Convertible Note, LLC first reported on Form ADV by LTS Capital Advisors (Private Equity Fund), GAV $883,000
LTS Capital Partners--Eyefluence B, LLC first reported on Form ADV by LTS Capital Advisors (Private Equity Fund), GAV $615,000
LTS Capital Partners--Fallbrook VI, LLC first reported on Form ADV by LTS Capital Advisors (Private Equity Fund), GAV $4,000,000
Eyefluence a Series of Lts Capital Partners II, LLC first reported on Form ADV by LTS Capital Advisors (Private Equity Fund), GAV $450,000
Hodyon Ar Series of Lts Capital Partners II, LLC first reported on Form ADV by LTS Capital Advisors (Private Equity Fund), GAV $2,000,000
Fallbrook V Series of Lts Capital Partners II LLC first reported on Form ADV by LTS Capital Advisors (Private Equity Fund), GAV $2,050,000
Viryd Series of Lts Capital Partners II, LLC first reported on Form ADV by LTS Capital Advisors (Private Equity Fund), GAV $288,465
Fallbrook IV Series of Lts Capital Partners II, LLC first reported on Form ADV by LTS Capital Advisors (Private Equity Fund), GAV $2,000,000
Viryd III Series of Lts Capital Partners II, LLC first reported on Form ADV by LTS Capital Advisors (Private Equity Fund), GAV $1,000,000
LTS Capital Partners I, LP first reported on Form ADV by LTS Capital Advisors (Private Equity Fund), GAV $1,612,016
Fallbrook III Series of Lts Capital Partners II, LLC first reported on Form ADV by LTS Capital Advisors (Private Equity Fund), GAV $695,000
Fallbrook II Series of Lts Capital Partners II, LLC first reported on Form ADV by LTS Capital Advisors (Private Equity Fund), GAV $150,000
Fallbrook Series of Lts Capital Partners II, LLC first reported on Form ADV by LTS Capital Advisors (Private Equity Fund), GAV $1,961,535
Viryd II Series of Lts Capital Partners II, LLC first reported on Form ADV by LTS Capital Advisors (Private Equity Fund), GAV $1,150,000
Bio2 Series of Lts Capital Partners II, LLC first reported on Form ADV by LTS Capital Advisors (Private Equity Fund), GAV $335,000